Results 31 to 40 of about 1,185 (135)

Medicine quality in high-income countries: The obstacles to comparative prevalence studies

Medicine Access @ Point of Care, 2021
The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importance of access to
Bernard David Naughton, Ebru Akgul
doaj   +1 more source

Review of drug recalls and quality of pharmaceutical products in Nepal

BMJ Open, 2022
Objectives To evaluate the pattern of substandard and falsified pharmaceutical products recall in Nepal.Setting We analysed drug recall notices issued by the Department of Drug Administration (DDA), Nepal, and systematically reviewed peer-reviewed ...
Astha Neupane, Maheshwor Bastakoti, Sabita Tamang, Basant Giri   +3 more
doaj   +1 more source

Countering counterfeits: The role of nurse practitioners in the fight against substandard and falsified medicines. [PDF]

J Am Assoc Nurse Pract
Substandard and falsified (SF) medicines, also referred to as counterfeit drugs, represent a global public health emergency. These products range from drugs with no or little active ingredient to medicines laced with illicit fentanyl. Counterfeits can be copies of brand, generic, or over-the-counter medicines.
Rusatira JC, Ahmed S.
europepmc   +4 more sources

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country

BMC Public Health, 2020
Background High prevalence of falsified, counterfeit and substandard medicines pose a threat to public health and treatment failure. This study aimed to investigate the quality of selected essential medicines available in Mongolia.
Daariimaa Khurelbat, Gereltuya Dorj, Bruce Sunderland, Tsetsegmaa Sanjjav, Enkhtuul Bayarsaikhan, Davaadagva Damdinjav, Gantuya Dorj, Altantuya Jigjidsuren, Oyun Lkhagvasuren, Baasandorj Erdenetsetseg   +9 more
doaj   +1 more source

Importance of medicine quality in achieving universal health coverage.

PLoS ONE, 2020
ObjectiveTo assess the importance of ensuring medicine quality in order to achieve universal health coverage (UHC).MethodsWe developed a systems map connecting medicines quality assurance systems with UHC goals to illustrate the ensuing impact of quality-
Sachiko Ozawa, Colleen R Higgins, Tatenda T Yemeke, Jude I Nwokike, Lawrence Evans, Mustapha Hajjou, Victor S Pribluda   +6 more
doaj   +1 more source

Stemming the Global Trade in Falsified and Substandard Medicines

JAMA, 2013
WHEN HIPPOCRATES ADVISED PHYSICIANS TO never give a deadly drug, he assumed they would know for sure that the medicines they prescribed were safe. Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice.
Gostin, Lawrence O., Buckley, Gillian J., Kelley, Patrick W.   +2 more
openaire   +3 more sources

Substandard and falsified medicines

JMIR Public Health and Surveillance, 2021
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standardized methods exist to estimate the prevalence of either substandard or falsified medicines. This is, in
Pisani, Elizabeth, Hasnida, Amalia, Rahmi, Mawaddati, Kok, Maarten Olivier, Harsono, Steven, Anggriani, Yusi   +5 more
openaire   +2 more sources

Discrimination of Falsified Erectile Dysfunction Medicines by Use of an Ultra-Compact Raman Scattering Spectrometer

Pharmacy, 2020
Substandard and falsified medicines are often reported worldwide. An accurate and rapid detection method for falsified medicines is needed to prevent human health hazards. Raman scattering spectroscopy has emerged as a non-destructive analysis method for
Tomoko Sanada, Naoko Yoshida, Kazuko Kimura, Hirohito Tsuboi   +3 more
doaj   +1 more source

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.

PLoS ONE, 2017
BackgroundSubstandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly
Albert Petersen, Nadja Held, Lutz Heide, Difäm-EPN Minilab Survey Group   +3 more
doaj   +1 more source

A Literature Review on the Global Burden and Impact of Substandard and Falsified Medicine

Annals of Public Health Issues, 2022
Abstract Substandard and falsified medicines are a global health concern negatively affecting individuals, the public, the pharmaceutical industry and governments all over the world. This review aims to examine the global prevalence of substandard and falsified medicines, its impact on health and the health system, including socio ...
Olanrewaju Olamide Popoola, Gulshan Madhur, Mariam Medhat Mehrim, Mark Odhiambo Omondi, Priscilla Owusu-Mensah, Saurabh Ashok Mamtani, Alison Ubong Etukakpan   +6 more
openaire   +1 more source